articleTop 1% cited

Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial

Biological Psychiatry · 2007 · Vol. 62(11) · pp. 1208–1216

John P. O’Reardon✉(University of Pennsylvania)H. Brent Solvason(Palo Alto University)Philip G. Janicak(Rush University Medical Center)Shirlene Sampson(Mayo Clinic)Keith Isenberg(Washington University in St. Louis)Ziad Nahas(Medical University of South Carolina)William M. McDonald(Emory University)David Avery(University of Washington)Paul B. Fitzgerald(Monash Alfred Psychiatry Research centre)Colleen Loo(UNSW Sydney)Mark A. Demitrack(Neuronetics (United States))Mark S. George(Medical University of South Carolina)Harold A. Sackeïm

View via DOI Publisher page

Transcranial Magnetic Stimulation Studies Pain Management and Treatment Migraine and Headache StudiesTranscranial magnetic stimulationRandomized controlled trialDepression (economics)MedicineDeep transcranial magnetic stimulationStimulationPsychiatryPhysical medicine and rehabilitationInternal medicine

MeSH terms

AdolescentAdultAgedAudiometryDepressive Disorder, MajorMajor Depressive DisorderDouble-Blind MethodFemaleHumansMaleMiddle AgedPsychiatric Status Rating ScalesTreatment OutcomeTranscranial Magnetic Stimulation

Citations

1,859

FWCI

49.12

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines